Oxcarbazepine adjunctive therapy for partial seizures in Japanese pediatric patients: a randomized double-blind placebo-controlled study and open-label extension study-Reference-Cited by-同舟云学术

Oxcarbazepine adjunctive therapy for partial seizures in Japanese pediatric patients: a randomized double-blind placebo-controlled study and open-label extension study

Published:2019 Issue:1 Volume:11 Page:30-45
ISSN:1882-5567
Container-title:Epilepsy & Seizure
language:en
Short-container-title:E&S

Author:

Fujiwara Tateki¹,Teshima Rie²,Sugiyama Ikuo²,Tsuchida Ken²,Ohtsuka Yoko³

Affiliation:

1. National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders

2. Novartis Pharma K.K.

3. Department of Child Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Publisher

The Japan Epilepsy Society

Subject

Clinical Neurology

Link

https://www.jstage.jst.go.jp/article/eands/11/1/11_30/_pdf

Reference18 articles.

1. [1] Berg AT, Levy SR, Testa FM, Shinnar S. Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement. Epilepsia 1999; 40: 439-444.

2. [2] Verrotti A, Loiacono G, Coppola G, Spalice A, Mohn A, Chiarelli F. Pharmacotherapy for children and adolescents with epilepsy. Expert Opin Pharmacother 2011; 12: 175-194.

3. [3] Baruzzi A, Albani F, Riva R. Oxcarbazepine: pharmacokinetic interactions and their clinical relevance. Epilepsia 1994; 35: S14-S19.

4. [4] Dam M, Ekberg R, Løyning Y, Waltimo O, Jakobsen K. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989; 3: 70-76.

5. [5] Faigle JW, Menge GP. Pharmacokinetic and metabolic features of oxcarbazepine and their clinical significance: comparison with carbamazepine. Int Clin Psychopharmacol 1990; 5: 73-82.